Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 346-356

  Gao, Xiaoling ^a   Zhao, Lei ^a   Wang, Shuhe ^a   Yang, Jie ^a   Yang, Xi ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE T CELL COSTIMULATOR; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HOST RESISTANCE; IMMUNOREGULATION; KNOCKOUT MOUSE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INTERLEUKIN-10; INTERLEUKIN-17; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84887901203     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00035     Document Type: Article

References (58)

1. Hutloff A, et al. (1999) ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397: 263-6.
2. Coyle AJ, et al. (2000) The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13: 95-105.
3. Yoshinaga SK, et al. (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402: 827-32.
4. Sato T, et al. (2004) Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease. Gastroenterology. 126: 829-39.
5. Dong C, et al. (2001) ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 409: 97-101.
6. McAdam AJ, et al. (2000) Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165: 5035-40.
7. McAdam AJ, et al. (2001) ICOS is critical for CD40-mediated antibody class switching. Nature. 409: 102-5.
8. Tafuri A, et al. (2001) ICOS is essential for effective T-helper-cell responses. Nature. 409: 105-9.
9. Kopf M, et al. (2000) Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192: 53-61.
10. Rottman JB, et al. (2001) The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2: 605-11.
11. Ozkaynak E, et al. (2001) Importance of ICOSB7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2: 591-6.
12. Subudhi SK, Alegre ML, Fu YX. (2005) The balance of immune responses: costimulation verse coinhibition. J. Mol. Med. (Berl). 83: 193-202.
13. Akbari O, et al. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-32.
14. Gao X, et al. (2012) CD8alpha+ and CD8alpha-DC subsets from BCG-infected mice inhibit allergic Th2-cell responses by enhancing Th1-cell and Treg-cell activity respectively. Eur. J. Immunol. 42: 165-75.
15. Han X, et al. (2006) Chlamydia infection induces ICOS ligand-expressing and IL-10-producing dendritic cells that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice. J. Immunol. 176: 5232-9.
16. Jiao L, et al. (2011) NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection. J. Immunol. 187: 401-11.
17. Dong C. (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-48.
18. Manel N, Unutmaz D, Littman DR. (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-9.
19. Khader SA, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. 2007. Nat. Immunol. 8: 369-77.
20. Das J, et al. (2009) Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206: 2407-16.
21. Korn T, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 448: 484-7.
22. Busse M, Krech M, Meyer-Bahlburg A, Hennig C, Hansen G. (2012) ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance. J. Immunol. 189: 1975-82.
23. Whitehead GS, et al. (2012) IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129: 207-15.
24. Hiraki S, et al. (2012) Neutralization of interleukin-10 or transforming growth factor-beta decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival. Surgery. 151: 313-22.
25. Hoffman BE, et al. (2011) Nonredundant roles of IL-10 and TGF-beta in suppression of immune responses to hepatic AAV-factor IX gene transfer. Mol. Ther. 19: 1263-72.
26. Zheng SG, Wang J, Horwitz DA. (2008) Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180: 7112-6.
27. Kimura A, Kishimoto T. (2010) IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 40: 1830-5.
28. Langrish CL, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-40.
29. Nakae S, et al. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U. S. A. 100: 5986-90.
30. Curtis MM, Way SS. (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 126: 177-85.
31. Zhang X, et al. (2009) A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J. Immunol. 183: 1291-300.
32. Umemura M, et al. (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178: 3786-96.
33. Sieve AN, et al. (2009) A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur. J. Immunol. 39: 426-38.
34. Bai H, et al. (2009) IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183: 5886-95.
35. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-41.
36. Kadkhoda K, et al. (2011) ICOS ligand expression is essential for allergic airway hyperresponsiveness. Int. Immunol. 23: 239-49.
37. Galicia G, et al. (2009) ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis. J. Clin. Immunol. 29: 426-33.
38. Gao X, et al. (2012) Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling. PLoS One. 7: e52657.
39. Ward ME. (1995) The immunobiology and immunopathology of chlamydial infections. APMIS. 103: 769-96.
40. Schachter J. (1978) Chlamydial infections (third of three parts). N. Engl. J. Med. 298: 540-9.
41. Morrison RP, Caldwell HD. (2002) Immunity to murine chlamydial genital infection. Infect. Immun. 70: 2741-51.
42. Igietseme JU, Smith K, Simmons A, Rayford PL. (1995) Effect of gamma-irradiation on the effector function of T lymphocytes in microbial control. Int. J. Radiat. Biol. 67: 557-64.
43. Cain TK, Rank RG. (1995) Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63: 1784-9.
44. Yang X. (2003) Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9: 67-73.
45. Lu H, et al. (2000) Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity. Mol. Med. 6: 604-12.
46. Yang X, Gartner J, Zhu L, Wang S, Brunham RC. (1999) IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162: 1010-7.
47. Holland MJ, Bailey RL, Hayes LF, Whittle HC, Mabey DC. (1993) Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J. Infect. Dis. 168: 1528-31.
48. Wang S, Fan Y, Brunham RC, Yang X. (1999) IFNgamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur. J. Immunol. 29: 3782-92.
49. Yang X, HayGlass KT, Brunham RC. (1996) Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J. Immunol. 156: 4338-44.
50. Su H, Caldwell HD. (1995) CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63: 3302-8.
51. Kadkhoda K, et al. (2010) Th1 cytokine responses fail to effectively control Chlamydia lung infection in ICOS ligand knockout mice. J. Immunol. 184: 3780-8.
52. Qiu H, et al. (2008) Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181: 2092-102.
53. Joyee AG, Uzonna J, Yang X. (2010) Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. J. Immunol. 184: 2095-106.
54. Joyee AG, et al. (2007) Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J. Immunol. 178: 1048-58.
55. Ivanov II, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126: 1121-33.
56. Ito T, et al. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204: 105-15.
57. Martin-Orozco N, et al. (2010) Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells. Cancer Res. 70: 9581-90.
58. Zhang YH, et al. (2012) IL-17A synergizes with IFN-gamma to upregulate iNOS and NO production and inhibit chlamydial growth. PLoS One. 7: e39214.